ocular side effects of glp 1 GLP-1 Receptor Agonists: A Review of Current Evidence and Safety Concerns Glucagon-Like Peptide 1 Receptor Agonists

Not anecdotal reports

All GLP-1s are excellent medicines for diabetes and weight control

Suitability: GLP-1 Agonists : Best suited for individuals with obesity or related health conditions who have not achieved success with lifestyle modifications

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has today, 11 June 2026, approved the first GLP-1 receptor agonist tablet for weight loss and weight management in the country

Retatrutide works by tackling some of the underlying causes of weight gain, not just the symptoms

This, in turn, decreases the risk of heart diseases, increasing the patient's adherence to the treatment